TDP-43, the signature protein of FTLD-U, is a neuronal activity-responsive factor.

PubWeight™: 2.91‹?› | Rank: Top 1%

🔗 View Article (PMID 18088371)

Published in J Neurochem on December 15, 2007

Authors

I-Fan Wang1, Lien-Szn Wu, Hsiang-Yu Chang, C-K James Shen

Author Affiliations

1: Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan.

Articles citing this ↘

(truncated to the top 100)

TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum Mol Genet (2010) 5.75

Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron (2013) 3.63

The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease. Brain Res (2012) 3.00

Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration. Nat Rev Neurosci (2011) 2.84

Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. J Neurosci (2010) 2.73

ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS. Proc Natl Acad Sci U S A (2010) 2.65

Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue. PLoS One (2010) 2.49

Knockdown of transactive response DNA-binding protein (TDP-43) downregulates histone deacetylase 6. EMBO J (2009) 2.37

Structural insights into TDP-43 in nucleic-acid binding and domain interactions. Nucleic Acids Res (2009) 2.37

Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery. J Proteome Res (2010) 2.35

Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability. Proc Natl Acad Sci U S A (2012) 2.14

TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97. J Neurosci (2010) 2.05

The seeds of neurodegeneration: prion-like spreading in ALS. Cell (2011) 2.03

TDP-43 overexpression enhances exon 7 inclusion during the survival of motor neuron pre-mRNA splicing. J Biol Chem (2008) 1.98

Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases. J Neurol (2009) 1.85

Local RNA translation at the synapse and in disease. J Neurosci (2011) 1.83

miRNA malfunction causes spinal motor neuron disease. Proc Natl Acad Sci U S A (2010) 1.83

Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-U. J Exp Med (2010) 1.78

Functional mapping of the interaction between TDP-43 and hnRNP A2 in vivo. Nucleic Acids Res (2009) 1.77

Frontotemporal dementia and amyotrophic lateral sclerosis-associated disease protein TDP-43 promotes dendritic branching. Mol Brain (2009) 1.65

TDP-43 is directed to stress granules by sorbitol, a novel physiological osmotic and oxidative stressor. Mol Cell Biol (2010) 1.64

Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations. Neuron (2014) 1.63

TDP-43 and FUS RNA-binding proteins bind distinct sets of cytoplasmic messenger RNAs and differently regulate their post-transcriptional fate in motoneuron-like cells. J Biol Chem (2012) 1.50

TDP-43 in aging and Alzheimer's disease - a review. Int J Clin Exp Pathol (2011) 1.46

Neurodegeneration the RNA way. Prog Neurobiol (2011) 1.43

Misregulated RNA processing in amyotrophic lateral sclerosis. Brain Res (2012) 1.42

Mimicking aspects of frontotemporal lobar degeneration and Lou Gehrig's disease in rats via TDP-43 overexpression. Mol Ther (2009) 1.42

TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies. Trends Mol Med (2011) 1.38

TDP-43 aggregation in neurodegeneration: are stress granules the key? Brain Res (2012) 1.35

Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol (2013) 1.32

The C-terminal TDP-43 fragments have a high aggregation propensity and harm neurons by a dominant-negative mechanism. PLoS One (2010) 1.32

VCP mutations causing frontotemporal lobar degeneration disrupt localization of TDP-43 and induce cell death. J Biol Chem (2009) 1.31

Ultrastructural localization of TDP-43 in filamentous neuronal inclusions in various neurodegenerative diseases. Acta Neuropathol (2008) 1.31

Neuropathology of non-Alzheimer degenerative disorders. Int J Clin Exp Pathol (2009) 1.27

Molecular neuropathology of TDP-43 proteinopathies. Int J Mol Sci (2009) 1.26

Targeted depletion of TDP-43 expression in the spinal cord motor neurons leads to the development of amyotrophic lateral sclerosis-like phenotypes in mice. J Biol Chem (2012) 1.26

The ALS disease protein TDP-43 is actively transported in motor neuron axons and regulates axon outgrowth. Hum Mol Genet (2012) 1.25

Molecular basis of UG-rich RNA recognition by the human splicing factor TDP-43. Nat Struct Mol Biol (2013) 1.25

Review: transactive response DNA-binding protein 43 (TDP-43): mechanisms of neurodegeneration. Neuropathol Appl Neurobiol (2010) 1.19

Wild-type and A315T mutant TDP-43 exert differential neurotoxicity in a Drosophila model of ALS. Hum Mol Genet (2011) 1.18

The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons. Hum Mol Genet (2013) 1.11

Regulation of autophagy by neuropathological protein TDP-43. J Biol Chem (2011) 1.10

TDP-43: the relationship between protein aggregation and neurodegeneration in amyotrophic lateral sclerosis and frontotemporal lobar degeneration. FEBS J (2011) 1.09

RNA processing pathways in amyotrophic lateral sclerosis. Neurogenetics (2010) 1.08

Update on recent molecular and genetic advances in frontotemporal lobar degeneration. J Neuropathol Exp Neurol (2008) 1.08

RNA-mediated toxicity in neurodegenerative disease. Mol Cell Neurosci (2012) 1.07

Redox signalling directly regulates TDP-43 via cysteine oxidation and disulphide cross-linking. EMBO J (2011) 1.07

Frontotemporal lobar degeneration with TDP-43 proteinopathy and chromosome 9p repeat expansion in C9ORF72: clinicopathologic correlation. Neuropathology (2012) 1.06

Quantitative analysis of the detergent-insoluble brain proteome in frontotemporal lobar degeneration using SILAC internal standards. J Proteome Res (2012) 1.05

The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia. Curr Opin Neurol (2008) 1.05

Coaggregation of RNA-binding proteins in a model of TDP-43 proteinopathy with selective RGG motif methylation and a role for RRM1 ubiquitination. PLoS One (2012) 1.05

The truncated C-terminal RNA recognition motif of TDP-43 protein plays a key role in forming proteinaceous aggregates. J Biol Chem (2013) 1.05

Molecular determinants of the axonal mRNA transcriptome. Dev Neurobiol (2013) 1.04

Smaug1 mRNA-silencing foci respond to NMDA and modulate synapse formation. J Cell Biol (2011) 1.00

Hyperphosphorylation as a defense mechanism to reduce TDP-43 aggregation. PLoS One (2011) 1.00

ALS-linked mutations enlarge TDP-43-enriched neuronal RNA granules in the dendritic arbor. J Neurosci (2014) 1.00

The self-interaction of native TDP-43 C terminus inhibits its degradation and contributes to early proteinopathies. Nat Commun (2012) 0.99

Prion-like nuclear aggregation of TDP-43 during heat shock is regulated by HSP40/70 chaperones. Hum Mol Genet (2013) 0.99

Neuronal sensitivity to TDP-43 overexpression is dependent on timing of induction. Acta Neuropathol (2012) 0.97

Neuronal function and dysfunction of Drosophila dTDP. PLoS One (2011) 0.96

Altered microRNA expression profile in Amyotrophic Lateral Sclerosis: a role in the regulation of NFL mRNA levels. Mol Brain (2013) 0.95

TDP-43 in neurodegenerative disorders. Expert Opin Biol Ther (2008) 0.94

Cognitive decline typical of frontotemporal lobar degeneration in transgenic mice expressing the 25-kDa C-terminal fragment of TDP-43. Am J Pathol (2011) 0.92

Synaptic activity regulated mRNA-silencing foci for the fine tuning of local protein synthesis at the synapse. Commun Integr Biol (2012) 0.92

Genome-wide approaches to dissect the roles of RNA binding proteins in translational control: implications for neurological diseases. Front Neurosci (2012) 0.91

RNA-binding proteins in neurodegenerative disease: TDP-43 and beyond. Wiley Interdiscip Rev RNA (2011) 0.90

Disease causing mutants of TDP-43 nucleic acid binding domains are resistant to aggregation and have increased stability and half-life. Proc Natl Acad Sci U S A (2014) 0.89

Motor neurons and glia exhibit specific individualized responses to TDP-43 expression in a Drosophila model of amyotrophic lateral sclerosis. Dis Model Mech (2013) 0.88

Rodent models of TDP-43 proteinopathy: investigating the mechanisms of TDP-43-mediated neurodegeneration. J Mol Neurosci (2011) 0.87

Reversible behavioral phenotypes in a conditional mouse model of TDP-43 proteinopathies. J Neurosci (2014) 0.87

Fragile X protein mitigates TDP-43 toxicity by remodeling RNA granules and restoring translation. Hum Mol Genet (2015) 0.86

TDP-43 in central nervous system development and function: clues to TDP-43-associated neurodegeneration. Biol Chem (2012) 0.85

The emerging roles of microRNAs in the pathogenesis of frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) spectrum disorders. J Neurogenet (2014) 0.85

TARDBP mutation analysis in TDP-43 proteinopathies and deciphering the toxicity of mutant TDP-43. J Alzheimers Dis (2013) 0.85

Astrocytic TDP-43 pathology in Alexander disease. J Neurosci (2014) 0.85

An acetylation switch controls TDP-43 function and aggregation propensity. Nat Commun (2015) 0.85

Futsch/MAP1B mRNA is a translational target of TDP-43 and is neuroprotective in a Drosophila model of amyotrophic lateral sclerosis. J Neurosci (2014) 0.84

TAR DNA-binding protein-43 in amyotrophic lateral sclerosis, frontotemporal lobar degeneration, and Alzheimer disease. Acta Neuropathol (2008) 0.84

Linking RNA Dysfunction and Neurodegeneration in Amyotrophic Lateral Sclerosis. Neurotherapeutics (2015) 0.83

Caspase-cleaved TAR DNA-binding protein-43 in Pick's disease. Int J Physiol Pathophysiol Pharmacol (2009) 0.83

The function of RNA-binding proteins at the synapse: implications for neurodegeneration. Cell Mol Life Sci (2015) 0.83

Divergent phenotypes in mutant TDP-43 transgenic mice highlight potential confounds in TDP-43 transgenic modeling. PLoS One (2014) 0.82

Multiple roles and interaction factors of an E-box element in Chlamydomonas reinhardtii. Plant Physiol (2010) 0.82

Axonal transport defects are a common phenotype in Drosophila models of ALS. Hum Mol Genet (2016) 0.80

Proteomic Analysis of Dynein-Interacting Proteins in Amyotrophic Lateral Sclerosis Synaptosomes Reveals Alterations in the RNA-Binding Protein Staufen1. Mol Cell Proteomics (2015) 0.80

Mitochondrial dysfunction in amyotrophic lateral sclerosis - a valid pharmacological target? Br J Pharmacol (2014) 0.80

Neuropathology of Amyotrophic Lateral Sclerosis and Its Variants. Neurol Clin (2015) 0.80

TDP-43/FUS in motor neuron disease: Complexity and challenges. Prog Neurobiol (2016) 0.79

Super-Resolution Microscopy Reveals Presynaptic Localization of the ALS/FTD Related Protein FUS in Hippocampal Neurons. Front Cell Neurosci (2016) 0.79

Dendritic protein synthesis in the normal and diseased brain. Neuroscience (2012) 0.79

Neuronal-specific overexpression of a mutant valosin-containing protein associated with IBMPFD promotes aberrant ubiquitin and TDP-43 accumulation and cognitive dysfunction in transgenic mice. Am J Pathol (2013) 0.79

The evolutionary scope and neurological disease linkage of yeast-prion-like proteins in humans. Biol Direct (2016) 0.78

Comparative quantitative study of 'signature' pathological lesions in the hippocampus and adjacent gyri of 12 neurodegenerative disorders. J Neural Transm (Vienna) (2015) 0.78

Frontotemporal Lobar Degeneration and MicroRNAs. Front Aging Neurosci (2016) 0.78

Aberrant RNA homeostasis in amyotrophic lateral sclerosis: potential for new therapeutic targets? Neurodegener Dis Manag (2014) 0.78

TDP-43 regulates β-adducin (Add2) transcript stability. RNA Biol (2014) 0.78

Cytoplasmic inclusions of TDP-43 in neurodegenerative diseases: a potential role for caspases. Histol Histopathol (2009) 0.78

Similar dose-dependence of motor neuron cell death caused by wild type human TDP-43 and mutants with ALS-associated amino acid substitutions. J Biomed Sci (2013) 0.78

The role of an E-box element: multiple frunctions and interacting partners. Plant Signal Behav (2010) 0.78

Disease animal models of TDP-43 proteinopathy and their pre-clinical applications. Int J Mol Sci (2013) 0.77

Articles by these authors ⇆

Structural diversity and functional implications of the eukaryotic TDP gene family. Genomics (2004) 3.51

TDP-43, a neuro-pathosignature factor, is essential for early mouse embryogenesis. Genesis (2010) 2.31

Higher order arrangement of the eukaryotic nuclear bodies. Proc Natl Acad Sci U S A (2002) 1.99

TDP-43 overexpression enhances exon 7 inclusion during the survival of motor neuron pre-mRNA splicing. J Biol Chem (2008) 1.98

Rate of evolution in brain-expressed genes in humans and other primates. PLoS Biol (2007) 1.87

TDP-43: an emerging new player in neurodegenerative diseases. Trends Mol Med (2008) 1.70

DEAD box RhlB RNA helicase physically associates with exoribonuclease PNPase to degrade double-stranded RNA independent of the degradosome-assembling region of RNase E. J Biol Chem (2002) 1.41

Rapidly evolving genes in human. I. The glycophorins and their possible role in evading malaria parasites. Mol Biol Evol (2003) 1.35

Targeted depletion of TDP-43 expression in the spinal cord motor neurons leads to the development of amyotrophic lateral sclerosis-like phenotypes in mice. J Biol Chem (2012) 1.26

Epigenetic regulation of the Drosophila chromosome 4 by the histone H3K9 methyltransferase dSETDB1. Proc Natl Acad Sci U S A (2007) 1.17

Regulation of autophagy by neuropathological protein TDP-43. J Biol Chem (2011) 1.10

DNA methyltransferase gene dDnmt2 and longevity of Drosophila. J Biol Chem (2004) 1.10

The eukaryotic DNMT2 genes encode a new class of cytosine-5 DNA methyltransferases. J Biol Chem (2003) 1.09

The self-interaction of native TDP-43 C terminus inhibits its degradation and contributes to early proteinopathies. Nat Commun (2012) 0.99

Substitution rate and structural divergence of 5'UTR evolution: comparative analysis between human and cynomolgus monkey cDNAs. Mol Biol Evol (2005) 0.97

Neuronal function and dysfunction of Drosophila dTDP. PLoS One (2011) 0.96

Sumoylation of p45/NF-E2: nuclear positioning and transcriptional activation of the mammalian beta-like globin gene locus. Mol Cell Biol (2005) 0.93

Ankrd17, an ubiquitously expressed ankyrin factor, is essential for the vascular integrity during embryogenesis. FEBS Lett (2009) 0.89

Transformation of yeast by infectious prion particles. Methods (2006) 0.87

Erythroid gene suppression by NF-kappa B. J Biol Chem (2003) 0.86

Developmental silencing of human zeta-globin gene expression is mediated by the transcriptional repressor RREB1. J Biol Chem (2010) 0.85

Actin-based modeling of a transcriptionally competent nuclear substructure induced by transcription inhibition. Exp Cell Res (2006) 0.82

Eukaryotic methyl-CpG-binding domain proteins and chromatin modification. Eukaryot Cell (2003) 0.81

Seasonal distribution of potentially pathogenic Acanthamoeba species from drinking water reservoirs in Taiwan. Environ Sci Pollut Res Int (2014) 0.79

Detection of mercury ions based on mercury-induced switching of enzyme-like activity of platinum/gold nanoparticles. Nanoscale (2012) 0.78

Enhancing three bliss concepts among nursing home elders in Taiwan. J Clin Nurs (2010) 0.78

A mass spectrometry-based immunosensor for bacteria using antibody-conjugated gold nanoparticles. Chem Commun (Camb) (2012) 0.75